Hantavirus and COVID-19 differ fundamentally in how they spread and their impact on human health, according to public health data.

Understanding these differences is critical as officials address an outbreak on the MV Hondius cruise ship in Caribbean waters. While both are respiratory threats, the biology of hantavirus makes it an unlikely candidate for a global pandemic.

Hantavirus is primarily transmitted when people inhale aerosolized rodent excreta [1]. Because the virus requires rodent exposure and does not transmit efficiently between humans, it remains a rare occurrence [1], [2]. In contrast, SARS-CoV-2, the virus that causes COVID-19, spreads easily between people via respiratory droplets [1], [3].

The two viruses also differ significantly in their lethality. Hantavirus has a case fatality rate of approximately 38% [4]. This is substantially higher than the global average case fatality rate for COVID-19, which is about 1% [4].

Despite the higher death rate associated with hantavirus, the lack of human-to-human contagion limits its reach. While some reports have suggested the spread of hantavirus is similar to the early start of the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention said that human-to-human transmission of hantavirus is rare [1], [5].

Medical experts said the differences stem from the viruses' biology. COVID-19 is a highly contagious respiratory virus designed for rapid human spread, whereas hantavirus depends on specific animal vectors to reach human hosts [1], [4].

“Hantavirus has a case fatality rate of approximately 38%.”

While the high fatality rate of hantavirus is alarming, its inability to spread easily between humans prevents it from mirroring the trajectory of the COVID-19 pandemic. The risk remains localized to environments with rodent infestations rather than posing a systemic threat to global population centers.